vs
Side-by-side financial comparison of GYRE THERAPEUTICS, INC. (GYRE) and Ladder Capital Corp (LADR). Click either name above to swap in a different company.
GYRE THERAPEUTICS, INC. is the larger business by last-quarter revenue ($37.2M vs $22.3M, roughly 1.7× Ladder Capital Corp). Ladder Capital Corp runs the higher net margin — 71.0% vs -3.7%, a 74.7% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs -18.0%). Ladder Capital Corp produced more free cash flow last quarter ($78.7M vs $-5.8M). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs -22.5%).
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
Ladder Capital Corp is a leading commercial real estate finance firm operating primarily across the United States. It originates and manages a diversified portfolio of senior secured commercial mortgage loans, mezzanine debt, commercial mortgage-backed securities, and direct real estate assets, serving property owners, operators and developers across major market segments.
GYRE vs LADR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.2M | $22.3M |
| Net Profit | $-1.4M | $15.9M |
| Gross Margin | 95.3% | — |
| Operating Margin | 0.3% | 69.5% |
| Net Margin | -3.7% | 71.0% |
| Revenue YoY | 33.4% | -18.0% |
| Net Profit YoY | -340.1% | -49.4% |
| EPS (diluted) | $-0.01 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $37.2M | $22.3M | ||
| Q3 25 | $30.6M | $27.8M | ||
| Q2 25 | $26.8M | $21.5M | ||
| Q1 25 | $22.1M | $20.3M | ||
| Q4 24 | $27.9M | $27.2M | ||
| Q3 24 | $25.5M | $38.4M | ||
| Q2 24 | $25.2M | $34.3M | ||
| Q1 24 | $27.2M | $37.1M |
| Q4 25 | $-1.4M | $15.9M | ||
| Q3 25 | $5.9M | $19.2M | ||
| Q2 25 | $1.6M | $17.1M | ||
| Q1 25 | $3.7M | $11.6M | ||
| Q4 24 | $569.0K | $31.3M | ||
| Q3 24 | $2.9M | $27.6M | ||
| Q2 24 | $4.5M | $32.1M | ||
| Q1 24 | $9.9M | $16.4M |
| Q4 25 | 95.3% | — | ||
| Q3 25 | 94.7% | — | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | 95.8% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 96.4% | — |
| Q4 25 | 0.3% | 69.5% | ||
| Q3 25 | 22.7% | 72.4% | ||
| Q2 25 | 8.1% | 96.7% | ||
| Q1 25 | 10.3% | 52.7% | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 16.6% | 74.1% | ||
| Q2 24 | 12.7% | 90.4% | ||
| Q1 24 | 29.7% | 49.4% |
| Q4 25 | -3.7% | 71.0% | ||
| Q3 25 | 19.4% | 69.0% | ||
| Q2 25 | 5.9% | 79.5% | ||
| Q1 25 | 16.9% | 56.8% | ||
| Q4 24 | 2.0% | 115.1% | ||
| Q3 24 | 11.2% | 71.7% | ||
| Q2 24 | 18.0% | 93.6% | ||
| Q1 24 | 36.6% | 44.2% |
| Q4 25 | $-0.01 | $0.13 | ||
| Q3 25 | $0.03 | $0.15 | ||
| Q2 25 | $0.00 | $0.14 | ||
| Q1 25 | $0.00 | $0.09 | ||
| Q4 24 | $0.00 | $0.25 | ||
| Q3 24 | $0.01 | $0.22 | ||
| Q2 24 | $0.01 | $0.26 | ||
| Q1 24 | $0.03 | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $38.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $106.0M | $1.5B |
| Total Assets | $166.1M | $5.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | $38.0M | ||
| Q3 25 | $60.0M | $49.4M | ||
| Q2 25 | $54.4M | $134.9M | ||
| Q1 25 | $29.9M | $479.8M | ||
| Q4 24 | $26.7M | $1.3B | ||
| Q3 24 | $25.1M | $1.6B | ||
| Q2 24 | $25.1M | $1.2B | ||
| Q1 24 | $37.4M | $1.2B |
| Q4 25 | $106.0M | $1.5B | ||
| Q3 25 | $101.9M | $1.5B | ||
| Q2 25 | $92.0M | $1.5B | ||
| Q1 25 | $68.1M | $1.5B | ||
| Q4 24 | $63.3M | $1.5B | ||
| Q3 24 | $63.2M | $1.5B | ||
| Q2 24 | $60.4M | $1.5B | ||
| Q1 24 | $56.6M | $1.5B |
| Q4 25 | $166.1M | $5.2B | ||
| Q3 25 | $159.4M | $4.7B | ||
| Q2 25 | $152.6M | $4.5B | ||
| Q1 25 | $129.8M | $4.5B | ||
| Q4 24 | $125.4M | $4.8B | ||
| Q3 24 | $125.2M | $4.8B | ||
| Q2 24 | $120.9M | $4.8B | ||
| Q1 24 | $122.0M | $5.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.6M | $87.0M |
| Free Cash FlowOCF − Capex | $-5.8M | $78.7M |
| FCF MarginFCF / Revenue | -15.5% | 352.4% |
| Capex IntensityCapex / Revenue | 0.4% | 37.4% |
| Cash ConversionOCF / Net Profit | — | 5.49× |
| TTM Free Cash FlowTrailing 4 quarters | $-180.0K | $118.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.6M | $87.0M | ||
| Q3 25 | $4.7M | $26.3M | ||
| Q2 25 | $2.1M | $44.0M | ||
| Q1 25 | $-129.0K | $-28.7M | ||
| Q4 24 | $-2.8M | $133.9M | ||
| Q3 24 | $1.7M | $169.0M | ||
| Q2 24 | $-5.5M | $45.4M | ||
| Q1 24 | $2.9M | $-20.4M |
| Q4 25 | $-5.8M | $78.7M | ||
| Q3 25 | $4.0M | $25.9M | ||
| Q2 25 | $1.8M | $43.4M | ||
| Q1 25 | $-251.0K | $-29.6M | ||
| Q4 24 | $-2.8M | $127.4M | ||
| Q3 24 | $1.0M | $166.0M | ||
| Q2 24 | $-6.9M | $44.9M | ||
| Q1 24 | $2.7M | $-21.7M |
| Q4 25 | -15.5% | 352.4% | ||
| Q3 25 | 13.1% | 93.1% | ||
| Q2 25 | 6.8% | 201.6% | ||
| Q1 25 | -1.1% | -145.6% | ||
| Q4 24 | -10.1% | 468.2% | ||
| Q3 24 | 4.1% | 432.1% | ||
| Q2 24 | -27.5% | 131.0% | ||
| Q1 24 | 9.8% | -58.6% |
| Q4 25 | 0.4% | 37.4% | ||
| Q3 25 | 2.2% | 1.7% | ||
| Q2 25 | 1.0% | 2.9% | ||
| Q1 25 | 0.6% | 4.3% | ||
| Q4 24 | 0.2% | 23.9% | ||
| Q3 24 | 2.7% | 7.8% | ||
| Q2 24 | 5.8% | 1.3% | ||
| Q1 24 | 0.9% | 3.7% |
| Q4 25 | — | 5.49× | ||
| Q3 25 | 0.79× | 1.37× | ||
| Q2 25 | 1.32× | 2.57× | ||
| Q1 25 | -0.03× | -2.49× | ||
| Q4 24 | -4.85× | 4.27× | ||
| Q3 24 | 0.60× | 6.13× | ||
| Q2 24 | -1.21× | 1.41× | ||
| Q1 24 | 0.29× | -1.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
